癌症研究
胰腺癌
免疫系统
免疫疗法
肿瘤微环境
细胞周期蛋白依赖激酶1
癌细胞
癌症
医学
免疫检查点
生物
免疫学
细胞周期
内科学
作者
Jin Huang,Pan Chen,Ke Liu,Jiao Liu,Bo Zhou,Runliu Wu,Peng Qiu,Zexian Liu,Changfeng Li,Guido Kroemer,Michael T. Lotze,Herbert J. Zeh,Rui Kang,Daolin Tang
出处
期刊:Gut
[BMJ]
日期:2020-08-14
卷期号:70 (5): 890-899
被引量:118
标识
DOI:10.1136/gutjnl-2019-320441
摘要
CDK1/2/5 kinase activity is essential for IFNG-mediated cancer immunoevasion. CDK1/2/5 inhibition by dinaciclib provides a novel strategy to overcome IFNG-triggered acquired resistance in pancreatic tumour immunity.
科研通智能强力驱动
Strongly Powered by AbleSci AI